Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. The company is headquartered in New Brunswick, New Jersey and currently employs 138,100 full-time employees. The firm's primary focus is products related to human health and well-being. The firm operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolism. Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, cardiovascular, and vision fields. These products are distributed to wholesalers, hospitals and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eyecare professionals, and clinics.
The most recent EPS for Johnson & Johnson is $2.46, not beating expectations of $2.46.
How did Johnson & Johnson JNJ's revenue perform in the last quarter?
Johnson & Johnson revenue for the last quarter is $2.46
What is the revenue estimate for Johnson & Johnson?
According to 16 of Wall street analyst, the revenue estimate of Johnson & Johnson range from $25.44B to $21.95B
What's the earning quality score for Johnson & Johnson?
Johnson & Johnson has a earning quality score of A/73.45719. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Johnson & Johnson report earnings?
Johnson & Johnson next earnings report is expected in 2026-04-21
What are Johnson & Johnson's expected earnings?
Johnson & Johnson expected earnings is $24.4B, according to wall-street analysts.
Did Johnson & Johnson beat earnings expectations?
Johnson & Johnson recent earnings of $24.56B beat expectations.